The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Treatment with bevacizumab in patients with metastatic colorectal cancer (mCRC).
Janja Ocvirk
No relevant relationships to disclose
Martina Rebersek
No relevant relationships to disclose
Marko Boc
No relevant relationships to disclose
Maja Ebert Motara
No relevant relationships to disclose
Tanja Mesti
No relevant relationships to disclose